Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina
C. Rojas-Roque,C. Silvestrini,F. Argento,D. Sugg,F. Augustovski,J. Coelli and N. Espinola. Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics – Open. 2024:10.1007/s41669-024-00495-6.